Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125670222 | 12567022 | 2 | F | 20160111 | 20160719 | 20160718 | 20160726 | EXP | HR-HALMED-2016-01783 | PHHY2016HR096651 | NOVARTIS | 0.00 | A | M | Y | 0.00000 | 20160726 | OT | HR | HR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125670222 | 12567022 | 1 | SS | LEPONEX / CLOZARIL (CLOZAPINE) | CLOZAPINE | 1 | Oral | 25 MG, (55 TABLETS) | 0 | 25 | MG | TABLET | |||||||
125670222 | 12567022 | 2 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 200 MG,(43 TABLETS) | 16608 | 200 | MG | ||||||||
125670222 | 12567022 | 3 | SS | DULOXETINE. | DULOXETINE | 1 | Oral | 60 MG, (17 TABLETS) | 0 | 60 | MG | TABLET | |||||||
125670222 | 12567022 | 4 | SS | APAURIN | DIAZEPAM | 1 | Oral | 5 MG,(20 TABLETS) | 0 | 5 | MG | ||||||||
125670222 | 12567022 | 5 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Oral | 400 MG, (37 TABLETS) | 0 | 400 | MG | COATED TABLET | |||||||
125670222 | 12567022 | 6 | SS | MODITEN | FLUPHENAZINE HYDROCHLORIDE | 1 | Oral | 2.5 MG,(37 TABLETS) | 0 | 2.5 | MG | ||||||||
125670222 | 12567022 | 7 | SS | SEROXAT | PAROXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, (27TABLET) | 0 | 20 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125670222 | 12567022 | 1 | Product used for unknown indication |
125670222 | 12567022 | 2 | Product used for unknown indication |
125670222 | 12567022 | 3 | Product used for unknown indication |
125670222 | 12567022 | 4 | Product used for unknown indication |
125670222 | 12567022 | 5 | Product used for unknown indication |
125670222 | 12567022 | 6 | Product used for unknown indication |
125670222 | 12567022 | 7 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125670222 | 12567022 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125670222 | 12567022 | Loss of consciousness | |
125670222 | 12567022 | Respiratory failure | |
125670222 | 12567022 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125670222 | 12567022 | 1 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 2 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 3 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 4 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 5 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 6 | 20160111 | 20160111 | 0 | |
125670222 | 12567022 | 7 | 20160111 | 20160111 | 0 |